EC Panel Recommends Phased Approach to Risk Evaluation of Nanomaterials

Devices & Diagnostics Letter
A A
Manufacturers of medical devices that contain nanomaterials should use a phased approach to evaluate risk in order to avoid unnecessary testing, an expert committee of the European Commission recommends.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00